Responses of dopaminergic, serotonergic and noradrenergic networks to acute levo-tetrahydropalmatine administration in naïve rats detected at 9.4 T

Magnetic Resonance Imaging

Volumn 30, Issue 2, 2012, Pages 261-270

  Liu, Xiping ^a   Yang, Zheng ^b   Li, Rupeng ^a   Xie, Jun ^a   Yin, Qian ^a   Bloom, Alan S ^a   Li, Shi Jiang ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Beijing Institute of Basic Medical Sciences   (China)

Author keywords

BOLD; Levo tetrahydropalmatine; MRI; Pharmacological connectivity

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; CANNABINOID 1 RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; MU OPIATE RECEPTOR; MUSCARINIC M1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 7 RECEPTOR; TETRAHYDROPALMATINE;

ANIMAL EXPERIMENT; ARTICLE; BINDING COMPETITION; BRAIN REGION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG RECEPTOR BINDING; DRUG TARGETING; IMAGE ANALYSIS; MALE; NEUROIMAGING; NEUROPHARMACOLOGY; NONHUMAN; NORADRENERGIC SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SEROTONINERGIC SYSTEM;

ADRENERGIC NEURONS; ANIMALS; BERBERINE ALKALOIDS; BRAIN; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; MAGNETIC RESONANCE IMAGING; MALE; NERVE NET; RATS; RATS, SPRAGUE-DAWLEY; SEROTONERGIC NEURONS;

RATTUS;

EID: 84855481910     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2011.09.006     Document Type: Article

References (42)

1. Jin G.Z. Discoveries in the voyage of corydalis research 2001, Shanghai Science & Techonology, Shanghai.
2. Luo J.Y., et al. The effect of l-tetrahydropalmatine on cocaine induced conditioned place preference. Chin J Drug Depend 2003, (12):177-179.
3. Ren Y., et al. Levo-tetrahydropalmatine inhibits the expression of methamphetamine-induced conditioned place preference in rats. Chin J Drug Depend 2000, (9):182-186.
4. Liu Y.L., et al. Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats. Eur J Pharmacol 2009, 602(2-3):321-327.
5. Mantsch J.R., et al. Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats. Psychopharmacology (Berl) 2007, 192(4):581-591.
6. Xi Z.X., et al. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropharmacology 2007, 53(6):771-782.
7. Yang Z., et al. Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study. Acta Pharmacol Sin 2008, 29(7):781-788.
8. Marcenac F., Jin G.Z., Gonon F. Effect of l-tetrahydropalmatine on dopamine release and metabolism in the rat striatum. Psychopharmacology (Berl) 1986, 89(1):89-93.
9. Liu G.Q., Algeri S., Garattini S. d-l-tetrahydropalmatine as monoamine depletor. Arch Int Pharmacodyn Ther 1982, 258(1):39-50.
10. Chueh F.Y., et al. Hypotensive and bradycardic effects of dl-tetrahydropalmatine mediated by decrease in hypothalamic serotonin release in the rat. Jpn J Pharmacol 1995, 69(2):177-180.
11. Howell L.L., Kimmel H.L. Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 2008, 75(1):196-217.
12. Guillem K., et al. Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 2005, 25(38):8593-8600.
13. Gardner E.L., et al. A slow-onset, long-duration indanamine monoamine reuptake inhibitor as a potential maintenance pharmacotherapy for psychostimulant abuse: effects in laboratory rat models relating to addiction. Neuropharmacology 2006, 51(5):993-1003.
14. Bubar M.J., Cunningham K.A. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Prog Brain Res 2008, 172:319-346.
15. Salomon L., et al. Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc Natl Acad Sci U S A 2006, 103(19):7476-7481.
16. Garren S.T., Smith R.L., Piegorsch W.W. On a likelihood-based goodness-of-fit test of the beta-binomial model. Biometrics 2000, 56(3):947-950.
17. Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001, 5(2):143-156.
18. Xu G., et al. Task-modulation of functional synchrony between spontaneous low-frequency oscillations in the human brain detected by fMRI. Magn Reson Med 2006, 56(1):41-50.
19. Endo T., et al. Functional MRI of the brain detects neuropathic pain in experimental spinal cord injury. Pain 2008, 138(2):292-300.
20. Zhang W.F., et al. Effects of on tetrahydropalmatine peripheral vascular dopamine DA1 and DA2 receptor subtypes. China Journal of Chinese Materia Medica 2000, 25(8):498-500.
21. Di Chiara G. From rats to humans and return: testing addiction hypotheses by combined PET imaging and self-reported measures of psychostimulant effects. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'. Behav Pharmacol 2002, 13(5-6):371-377.
22. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron 2002, 36(2):229-240.
23. Contreras M., Ceric F., Torrealba F. Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium. Science 2007, 318(5850):655-658.
24. Rogers J.L., See R.E. Selective inactivation of the ventral hippocampus attenuates cue-induced and cocaine-primed reinstatement of drug-seeking in rats. Neurobiol Learn Mem 2007, 87(4):688-692.
25. Lasseter H.C., et al. Prefrontal cortical regulation of drug seeking in animal models of drug relapse. Curr Top Behav Neurosci 2010, 3:101-117.
26. See R.E., Elliott J.C., Feltenstein M.W. The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology (Berl) 2007, 194(3):321-331.
27. Everitt B.J., et al. Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 2008, 363(1507):3125-3135.
28. Volkow N.D., Fowler J.S., Wang G.J. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 2004, 47(Suppl 1):3-13.
29. Hu J.Y., Jin G.Z. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Zhongguo Yao Li Xue Bao 1999, 20(8):715-719.
30. Schwarz A.J., et al. Functional connectivity in the pharmacologically activated brain: resolving networks of correlated responses to d-amphetamine. Magn Reson Med 2007, 57(4):704-713.
31. Shmuel A., et al. Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1. Nat Neurosci 2006, 9(4):569-577.
32. Kastrup A., et al. Behavioral correlates of negative BOLD signal changes in the primary somatosensory cortex. Neuroimage 2008, 41(4):1364-1371.
33. Northoff G., et al. GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI. Nat Neurosci 2007, 10(12):1515-1517.
34. Luo F., et al. Attenuation of brain response to heroin correlates with the reinstatement of heroin-seeking in rats by fMRI. Neuroimage 2004, 22(3):1328-1335.
35. Febo M., et al. Imaging cocaine-induced changes in the mesocorticolimbic dopaminergic system of conscious rats. J Neurosci Methods 2004, 139(2):167-176.
36. Li S.J., et al. Heroin-induced negative BOLD signal in the nucleus accumbens of rat brain is related to neuronal inhibition. Proc Int Soc Magn Reson Med. 2003, 11:358.
37. Kufahl P.R., et al. Neural responses to acute cocaine administration in the human brain detected by fMRI. Neuroimage 2005, 28(4):904-914.
38. Lauritzen M. Reading vascular changes in brain imaging: is dendritic calcium the key?. Nat Rev Neurosci 2005, 6(1):77-85.
39. Lauritzen M., Gold L. Brain function and neurophysiological correlates of signals used in functional neuroimaging. J Neurosci 2003, 23(10):3972-3980.
40. Hara K., Harris R.A. The anesthetic mechanism of urethane: the effects on neurotransmitter-gated ion channels. Anesth Analg 2002, 94(2):313-318. [table of contents].
41. Sommers M.G., et al. Isoflurane anesthesia is a valuable alternative for alpha-chloralose anesthesia in the forepaw stimulation model in rats. NMR Biomed 2009, 22(4):414-418.
42. Schmidt K.F., et al. Hemodynamic and metabolic changes induced by cocaine in anesthetized rat observed with multimodal functional MRI. Psychopharmacology (Berl) 2006, 185(4):479-486.